Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that diagnosing hair loss requires evaluating multiple histological features, as no single feature is definitive on its own.

2011 dermatology discussions highlighted stem cell hair treatments, new lichen planopilaris therapies, skin side effects from cancer drugs, emerging allergens, and the link between food allergies and skin issues.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.

Denosumab treatment for osteoporosis can cause hair loss.

Hidradenitis suppurativa is a skin disease caused by the breakdown of the skin's natural immune barriers, especially around hair follicles.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

The conclusion is that genetic testing is important for diagnosing and treating various genetic hair disorders.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Melatonin may protect hair follicle cells from damage caused by a chemotherapy drug.

The book is a useful guide for identifying hair loss conditions with clear photos and treatment tips, recommended for skin and hair specialists.

The article concludes that creating a detailed map of normal human skin at the single-cell level is important.

Certain small molecules can promote hair growth by activating a cellular cleanup process called autophagy.

The conclusion is that understanding how hair follicle stem cells live or die is important for maintaining healthy tissue and repairing injuries, and could help treat hair loss, but there are still challenges to overcome.

The harlequin ichthyosis mouse mutation causes thick skin and early death, resembling a human skin disorder.

Mice with extra human KLK14 had hair and skin problems, including weaker cell bonds and inflammation, linked to Netherton syndrome.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Certain genetic changes in the LSS gene cause a rare skin and hair condition.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

Some antiseizure medications can cause reversible hair loss, with valproate, lamotrigine, and carbamazepine being the most common.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Patients with ichthyosis often experience symptoms similar to psoriasis and atopic dermatitis, suggesting that targeted therapies could improve their condition.

The absence of functional sebaceous glands causes hair follicle destruction and scarring alopecia.

Mouse tail skin has different keratinization near hair follicles and scales.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.

Children with systemic lupus erythematosus have different skin symptoms than adults.